Skip to main content

Military Health System

Utility Navigation Links

WEEKEND MAINTENANCE: The maintenance outage is scheduled for April 20th at 6:00am EST ending NLT Sunday, April 21st at 11:59pm Eastern EST. The TRICARE Manuals web site may be available intermittently during this period but it's usage is not recommended.

TRICARE Policy Manual 6010.60-M, April 1, 2015
Medicine
Chapter 7
Section 2.3
Family Planning
Issue Date:  August 26, 1985
Authority:  32 CFR 199.4(e)(3)
Revision:  C-115, August 7, 2023
1.0  POLICY
1.1  Medical contraceptives listed in Sections 2.1 and 2.2, as well as female tubal sterilization (see note below), are covered as the clinical preventive services benefit.
1.2  In addition to the medical contraceptives listed in Section 2.1, the family planning procedures listed below may be also cost-shared:
1.2.1  Prescription contraceptives, including diaphragms received in the pharmacy setting, and prescription contraceptives used as emergency contraceptives.
Note:  Implantable prescription contraceptives are covered if the U.S. Food and Drug Administration (FDA) approved and used for the labeled indication.
1.2.2  Surgical sterilization.
Note:  Female tubal sterilization procedures are covered with no-cost sharing when performed by an in-network provider for TRICARE Prime and TRICARE Select beneficiaries, effective January 1, 2023. However, cost-sharing may apply when performed by an out-of-network provider or when provided to non-Prime or Select beneficiaries (i.e., TRICARE for Life beneficiaries). See Section 2.2.
1.3  For preconception and prenatal carrier screening tests, see Chapter 6, Section 3.2.
2.0  EXCLUSIONS
2.1  Prophylactics (condoms).
2.2  Spermicidal foams, jellies, and sprays not requiring a prescription.
2.3  Services and supplies related to noncoital reproductive technologies, including but not limited to artificial insemination (including cost related to donors and semen banks), In Vitro Fertilization (IVF) and Gamete Intrafallopian Transfer (GIFT).
2.4  Male reversal of a surgical sterilization and reversal of a female tubal sterilization procedure, except medically necessary reversal of surgical sterilization for the treatment of a disease or injury (see Chapter 4, Sections 15.1 and 17.1).
2.5  For routine screening Papanicolaou (PAP) smear tests, routine gynelogic examinations, and related laboratory testing, see the Preventive Services policy.
2.6  The family planning benefit does not include screening PAP smear tests, routine gynelogic examinations, including related laboratory testing. However, family planning benefits may be allowed during an office visit for a screening PAP test.
- END -
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery